Japanese data is current through August 2018. All of the data comes from the Japanese Pharmaceuticals and Medical Devices Agency, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Japan.
데이터 추가 비고
"Regarding the enforcement of laws, etc. that revise part of the Pharmaceutical Affairs Law etc." (Pharmaceutical dishes 0806 No. 3 August 6, 26 26) Medical device program subject to transitional measures under the Supplementary Provisions